[HTML] sciencedirect.com

[HTML][HTML] Innate and adaptive immune responses toward nanomedicines

IM de Oliveira Viana, S Roussel, J Defrêne… - … Pharmaceutica Sinica B, 2021 - Elsevier
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …
被引用次数：40 相关文章

Innate and adaptive immune responses toward nanomedicines

IM de Oliveira Viana, S Roussel… - Acta …, 2021 - pubmed.ncbi.nlm.nih.gov
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …

Innate and adaptive immune responses toward nanomedicines

MO Iara, S ROUSSEL, J DEFRÊNE… - Acta Pharmaceutica …, 2021 - pesquisa.bvsalud.org
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …
[HTML] nih.gov

[HTML][HTML] Innate and adaptive immune responses toward nanomedicines

IM de Oliveira Viana, S Roussel, J Defrêne… - Acta Pharmaceutica …, 2021 - ncbi.nlm.nih.gov
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …

Innate and adaptive immune responses toward nanomedicines.

IMO Viana, S Roussel, J Defrêne, EM Lima… - Acta Pharmaceutica …, 2021 - europepmc.org
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …

Innate and adaptive immune responses toward nanomedicines.

IMO Viana, S Roussel, J Defrêne, EM Lima… - … Pharm Sin B, 2021 - pesquisa.bvsalud.org
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …